Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2012
06/14/2012US20120149573 Herbicidal bus-nitrogen-containing oxo and sulfono heterocycles
06/14/2012US20120148534 Methods and compositions of treating a flaviviridae family viral infection
06/14/2012US20120148514 N-alkyl lactam ethers, and compositions and uses thereof
06/14/2012US20120146264 Resin composition for laser engraving, relief printing plate precursor for laser engraving and process for producing same, and process for making relief printing plate
06/14/2012US20120146014 Aromatic amine derivatives and organic electroluminescent elements using same
06/14/2012US20120146012 Heterocyclic Radical or Diradical, The Dimers, Oligomers, Polymers, Dispiro Compounds and Polycycles Thereof, the Use Thereof, Organic Semiconductive Material and Electronic or Optoelectronic Component
06/14/2012US20120146008 Chrysene compounds for luminescent applications
06/14/2012CA2820838A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
06/14/2012CA2820408A1 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp-pla2
06/14/2012CA2819373A1 Bicyclic compounds as pim inhibitors
06/14/2012CA2819277A1 Novel triazole compounds iii
06/13/2012EP2463285A1 Co-crystals and pharmaceutical compositions comprising the same
06/13/2012EP2463284A1 Co-crystals and pharmaceutical compositions comprising the same
06/13/2012EP2463283A1 Fused phenyl Amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
06/13/2012EP2463278A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
06/13/2012EP2463265A2 Process for the preparation of insecticidal aryl pyrrolidines
06/13/2012EP2462144A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
06/13/2012EP2462136A1 Phenyl ethynyl derivatives as hepatitis c virus inhibitors
06/13/2012EP2462135A1 Bis-benzimidazole derivatives as hepatitis c virus inhibitors
06/13/2012EP2462134A1 N1-sulfonyl-5-fluoropyrimidinone derivatives
06/13/2012EP2462132A1 5-fluoropyrimidinone derivatives
06/13/2012EP2462126A1 Method for stereoselective synthesis of bicyclic heterocyclic compounds
06/13/2012EP2462123A1 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors
06/13/2012EP2462121A1 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
06/13/2012EP2461688A1 Pesticidal compositions
06/13/2012EP2461683A1 Bicyclic aryl sphingosine 1-phosphate analogs
06/13/2012EP1704145B1 Selective kinase inhibitors
06/13/2012EP1363705B1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
06/13/2012CN1997642B 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/13/2012CN102498110A 2- (LH-pyrazol-4-ylamino) -pyrimidine as kinase inhibitors
06/13/2012CN102498109A Piperazinyl 3-aminopyrrolidine derivatives as a CCR2 antagonist
06/13/2012CN102498095A Indoline derivatives
06/13/2012CN102498091A Glycine compound
06/13/2012CN102491972A Carbazole derivative, preparation method thereof, and application of carbazole derivative serving as anticancer drug
06/13/2012CN102491971A Chiral ((4-methyl-2-propyl-1H-benzimidazole-6-amide)-1-radical) methyl diphenyl compound, as well as preparation method and application thereof
06/13/2012CN102491970A Synthetic method for irbesartan
06/13/2012CN102491968A Method for preparing carbazolyl biaryl compound in aqueous phase
06/13/2012CN101646650B Sub-type selective azabicycloalkane derivatives
06/13/2012CN101541753B 2-aminoquinolines as 5-HT(5A) receptor antagonists
06/13/2012CN101439039B Fortifier
06/13/2012CN101429115B Process for producing trifluoro benzene acetic acid and sitagliptin
06/13/2012CN101406469B Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/12/2012US8198458 Non-nucleoside reverse transcriptase inhibitors
06/12/2012US8198448 Fused heterocyclic derivatives and methods of use
06/12/2012US8198314 Treatment of CRTH2-mediated diseases and conditions
06/12/2012US8198313 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/12/2012US8198309 N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides
06/12/2012US8198307 Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same
06/12/2012US8198280 N-hydroxyamide derivatives and use thereof
06/12/2012US8198276 Kinase inhibitor compounds
06/12/2012US8198274 Substituted indolyl and indazolyl derivatives and uses thereof
06/12/2012CA2595514C Kinase inhibitors
06/12/2012CA2475331C Synthesis of indole thiazole compounds as ligands for the ah receptor
06/07/2012WO2012075239A1 Serotonin reuptake inhibitors
06/07/2012WO2012074437A2 Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof
06/07/2012WO2012074135A1 Pyrimidine compound and use for pest control thereof
06/07/2012WO2012073995A1 Heteroaromatic ring compound and pest control application thereof
06/07/2012WO2012073254A1 A process for the preparation of pazopanib using novel intermediate
06/07/2012WO2012073017A1 Substituted benzopyrazin derivatives as fgfr kinase inhibitors for the treatment of cancer diseases
06/07/2012WO2012072033A1 Substituted 2,3-phthalazinone compounds and use thereof
06/07/2012WO2012037187A3 Preparation of crystalline bazedoxifene and its salts
06/07/2012WO2010073128A3 Fused imidazole derivatives as trpv3 antagonist
06/07/2012US20120142936 1-(sulfonyl)-n-phenylpyrrolidine-2-carboxamides for the identification of biological and pharmacological activity
06/07/2012US20120142922 Benzamide derivatives
06/07/2012US20120142921 Substituted hydrazide compounds and use thereof
06/07/2012US20120142916 Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
06/07/2012US20120142912 Polycyclic compounds, termed calixurenes, and uses thereof
06/07/2012US20120142749 Solid salt forms of a pyrrole substituted 2-indolinone
06/07/2012US20120142717 Compounds
06/07/2012US20120142716 4-pyrimidinesulfamide derivative
06/07/2012US20120142713 Crystalline forms of 6-(1h-imidazol-1-yl)-2-phenylquinazoline
06/07/2012US20120142711 Acid-labile trigger units
06/07/2012US20120142705 Isatin and oxindole compounds
06/07/2012US20120142702 Integrin-linked kinase inhibitors
06/07/2012US20120142698 Microbiocidal heterocycles
06/07/2012US20120142697 Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino)phenyl]-benzamide
06/07/2012US20120142696 Substituted indole/indazole-pyrimidinyl compounds
06/07/2012US20120142689 Serotonin reuptake inhibitors
06/07/2012US20120142687 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
06/07/2012US20120142686 Viral polymerase inhibitors
06/07/2012US20120142660 Aminopyrimidines useful as kinase inhibitors
06/07/2012US20120139410 Organic electroluminescence device and material for organic electroluminescence device
06/07/2012US20120138912 Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same
06/07/2012US20120138911 Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same
06/07/2012US20120138907 Light-emitting device material and light-emitting device
06/07/2012US20120138789 Phosphonium-Based Ionic Liquids and Uses
06/07/2012CA2832426A1 Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof
06/07/2012CA2819118A1 A process for the preparation of pazopanib using novel intermediate
06/07/2012CA2819009A1 Substituted benzopyrazin derivatives as fgfr kinase inhibitors for the treatment of cancer diseases
06/06/2012EP2461390A1 Organic electroluminescent element
06/06/2012EP2460798A2 Apaf-1 inhibitor compounds
06/06/2012EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative
06/06/2012EP2459563A2 5-ht3 receptor modulators, methods of making, and use thereof
06/06/2012EP2459551A1 Dihydrobenzoindazoles
06/06/2012EP2459550A2 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
06/06/2012EP2459541A1 Dihydropyrimidone amides as p2x7 modulators
06/06/2012EP2459529A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
06/06/2012EP2459197A1 Compounds for the reduction of -amyloid production
06/06/2012EP2231640B1 Beta-amino acid derivatives for treatment of diabetes
06/06/2012EP1620108B1 Pyrazole-amine compounds useful as kinase inhibitors
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 626